Search results
Showing 3501 to 3550 of 3765 results for treatment
Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.
Early Cancer Diagnosis: 75% of cases diagnosed at stage 1 or 2 by 2028.
committees and why she'd encourage you to get involved. Following my treatment for colorectal cancer, I wanted to contribute and improve...
Final decision on cerliponase alfa for Batten disease treatment confirmed
In final draft guidance published today we've confirmed that we’re unable to recommend cerliponase alfa (also called Brineura and made by BioMarin) for routine NHS use in treating neuronal ceroid lipofuscinosis type 2 (CLN2), a rare and life-limiting form of Batten disease.
Patients to receive medicines 3 to 6 months faster under 10-Year Health Plan
NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.
health technologies in the NHS, clinical guidelines on the management and treatment of particular conditions and its ongoing development...
NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,
Hundreds with rare inherited eye disease to benefit after NICE recommends treatment
NICE recommends idebenone for Leber's hereditary optic neuropathy following clinical evidence of vision improvement.
We're at the forefront of bringing better care to people. We help practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Science policy projects with NICE.
NICE approves first immunotherapy combination for endometrial cancer
Around 2,100 people with advanced womb cancer are set to benefit from a groundbreaking new treatment option, following our recommendation of pembrolizumab (Keytruda) in final draft guidance published today.
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
The principles that guide the development of NICE guidance and standards.
Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
April. Our aim was to create consistent guidelines and end rationing of treatment by postcode across the UK. First NICE guidance We...
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
A step-by-step timeline of the process we used to develop single technology appraisals (STA).
Thousands could benefit from first immunotherapy for severe birch tree pollen allergy
We have recommended the first under-the-tongue tablet immunotherapy shown to build long-term tolerance to allergens, which could help up to 27,000 people in England with moderate to severe birch tree pollen allergies.
Thousands more breast cancer patients to benefit from new NHS treatment
NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.
How NICE International is supporting evidence-based decision-making through the Regulatory Partnership for Growth Fund
NICE provisionally recommends leadless implantable pacemaker in draft guidance
A procedure for people with slow heart rhythms could be used more widely after it was recommended for NHS use in draft guidance.
NICE priority methodological research areas.
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
Our science policy and research programme team produces high-quality, impactful research.
Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.
NICE guidelines are evidence-based recommendations for health and care in England and Wales.
NICE's past research and projects
NICE responds to publication of the government's Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
A step-by-step summary about how we develop our technology appraisal guidance.
How voluntary and community sector organisations can help us develop guidance
How voluntary and community sector (VCS) organisations can help NICE develop guidance
Read NICE's patient and public involvement policy.
Mental health is one of the key clinical areas of health inequalities identified in NHS England’s Core20PLUS5 framework for children and young people.
To contact us, NICE's website is usually the quickest way to find the answer to a query.
In the Labonte model, physiological impacts refer to the direct effects on the body’s systems and functions due to factors such as stress, lifestyle choices, and environmental conditions.
Supporting the health and care system to implement virtual wards
Virtual wards (also known as hospital at home) provide hospital level care at home.
Referral points to virtual wards are similar to traditional models of care. Our guidance and advice can help you decide where to provide care and what to consider.
Positive experiences early in life are closely associated with better performance at school, better social and emotional development, improved work outcomes, higher income and better lifelong health, including longer life expectancy.
The Marmot Review summarised the importance the impact of addressing inequalities in health in later life and investing in the early years to preventing ill health later in life.
Making a positive impact: people and communities network case studies
Making a positive impact: NICE people and communities network case studies
We've created the guides and resources on this page to help people who are involved in developing NICE guidelines.
be to create a crisis plan, which would include advance decisions about treatment and support and potential triggers or indicators of...
Support for delivering quality, safety and efficiency in the optimisation of medicines.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.